Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Asset Utilization Ratio (2010 - 2026)

Charles River Laboratories International (CRL) posted Asset Utilization Ratio of 0.52 for Q2 2026, down 3.28% on a QoQ basis from 0.54 in Q1 2026, and down 1.51% year-over-year from 0.53 in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Asset Utilization Ratio (2010 - 2026) Analysis & Trends

Charles River Laboratories International has reported Asset Utilization Ratio for 17 years, with the latest figure at 0.52 in Q2 2026.

  • On a quarterly basis, Asset Utilization Ratio fell 1.51% year-over-year to 0.52 in Q2 2026; TTM through Jun 2026 was 0.52, a 1.51% decrease from a year earlier, with the FY2025 full-year figure at 0.55, up 6.31% from the prior year.
  • Asset Utilization Ratio was 0.52 for Q2 2026 at Charles River Laboratories International, down from 0.54 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.55 in Q3 2023, with the low at 0.5 in Q1 2024.
  • Average Asset Utilization Ratio over 5 years is 0.53, with a median of 0.53 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio climbed 8.1% in 2023, then decreased 7.13% in 2024.
  • Over 5 years, Asset Utilization Ratio stood at 0.53 in 2022, then decreased by 1.51% to 0.52 in 2023, then decreased by 0.22% to 0.52 in 2024, then advanced by 5.12% to 0.55 in 2025, then retreated by 4.41% to 0.52 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.52 (Q2 2026), 0.54 (Q1 2026), and 0.55 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 0.57
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 1.33
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 0.50
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 0.52
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 0.99
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 0.11
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 2.01
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 0.84
10 VivoSim Labs 1.37 Mn 1.37 Mn - 0.02
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 0.52
Mar 28, 2026 0.54
Dec 27, 2025 0.55
Sep 27, 2025 0.53
Jun 28, 2025 0.53
Mar 29, 2025 0.53
Dec 28, 2024 0.52
Sep 28, 2024 0.51
Jun 29, 2024 0.51
Mar 30, 2024 0.50
Dec 30, 2023 0.52
Sep 30, 2023 0.55
Jul 1, 2023 0.54
Apr 1, 2023 0.53
Dec 31, 2022 0.53
Sep 24, 2022 0.51
Jun 25, 2022 0.51
Mar 26, 2022 0.51
Dec 25, 2021 0.50
Sep 25, 2021 0.50